Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture. 1977

H Yamasaki, and E Fibach, and U Nudel, and I B Weinstein, and R A Rifkind, and P A Marks

Addition of the potent tumor promoter, 12-O-tetradecanoyl-phorbol-13-acetate (TPA), to murine erythroleukemia cell lines in suspension cultures inhibited both spontaneous differentiation and differentiation induced by hexamethylene bisacetamide (HMBA), dimethyl sulfoxide, or butyric acid. Inhibition was unrelated to cytotoxicity and was reversible. When several plant diterpenes were tested, there was a positive correlation between tumor-promoting activity and inhibition of differentiation. TPA inhibited HMBA-induced differentiation only if added prior to the time of commitment to differentiation, as assayed by scoring for differentiation after transfer of cells from HMBA to fresh medium without HMBA. TPA-mediated inhibition of differentiation was associated with a decrease in globin mRNA accumulation.

UI MeSH Term Description Entries
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D010703 Phorbol Esters Tumor-promoting compounds obtained from CROTON OIL (Croton tiglium). Some of these are used in cell biological experiments as activators of protein kinase C. Phorbol Diester,Phorbol Ester,Phorbol Diesters,Diester, Phorbol,Diesters, Phorbol,Ester, Phorbol,Esters, Phorbol
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003959 Diamines Organic chemicals which have two amino groups in an aliphatic chain. Diamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005914 Globins A superfamily of proteins containing the globin fold which is composed of 6-8 alpha helices arranged in a characterstic HEME enclosing structure. Globin

Related Publications

H Yamasaki, and E Fibach, and U Nudel, and I B Weinstein, and R A Rifkind, and P A Marks
July 1977, Proceedings of the National Academy of Sciences of the United States of America,
H Yamasaki, and E Fibach, and U Nudel, and I B Weinstein, and R A Rifkind, and P A Marks
June 1980, Biochemical and biophysical research communications,
H Yamasaki, and E Fibach, and U Nudel, and I B Weinstein, and R A Rifkind, and P A Marks
October 1987, Molecular and cellular biochemistry,
H Yamasaki, and E Fibach, and U Nudel, and I B Weinstein, and R A Rifkind, and P A Marks
December 1986, Cancer research,
H Yamasaki, and E Fibach, and U Nudel, and I B Weinstein, and R A Rifkind, and P A Marks
February 1993, Blood,
H Yamasaki, and E Fibach, and U Nudel, and I B Weinstein, and R A Rifkind, and P A Marks
January 1984, Advances in cancer research,
H Yamasaki, and E Fibach, and U Nudel, and I B Weinstein, and R A Rifkind, and P A Marks
September 1988, Molecular and cellular biology,
H Yamasaki, and E Fibach, and U Nudel, and I B Weinstein, and R A Rifkind, and P A Marks
March 1981, Experimental cell research,
H Yamasaki, and E Fibach, and U Nudel, and I B Weinstein, and R A Rifkind, and P A Marks
November 1978, Life sciences,
H Yamasaki, and E Fibach, and U Nudel, and I B Weinstein, and R A Rifkind, and P A Marks
December 1979, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!